US Stock MarketDetailed Quotes

SLNO Soleno Therapeutics

Watchlist
  • 45.1800
  • -0.0200-0.04%
Close Dec 20 16:00 ET
  • 45.1800
  • 0.00000.00%
Post 20:01 ET
1.95BMarket Cap-16.19P/E (TTM)

Soleno Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
747.51%79.34M
179.55%23.23M
182.42%23.07M
54.01%38.67M
106.52%12.83M
53.38%9.36M
34.84%8.31M
23.21%8.17M
-22.16%25.11M
-1.86%6.21M
Selling and administrative expenses
1,382.73%49.2M
243.61%10.89M
196.85%8.47M
36.95%13.48M
72.36%4.14M
42.28%3.32M
28.46%3.17M
7.98%2.85M
-8.90%9.84M
-7.47%2.4M
-General and administrative expense
1,382.73%49.2M
243.61%10.89M
196.85%8.47M
36.95%13.48M
72.36%4.14M
42.28%3.32M
28.46%3.17M
7.98%2.85M
-8.90%9.84M
-7.47%2.4M
Research and development costs
398.73%30.14M
140.07%12.34M
174.68%14.6M
65.01%25.19M
128.06%8.69M
60.25%6.04M
39.10%5.14M
33.30%5.32M
-28.84%15.27M
2.04%3.81M
Operating profit
-747.51%-79.34M
-179.55%-23.23M
-182.42%-23.07M
-54.01%-38.67M
-106.52%-12.83M
-53.38%-9.36M
-34.84%-8.31M
-23.21%-8.17M
22.16%-25.11M
1.86%-6.21M
Net non-operating interest income expense
1,966.67%3.6M
1,950.34%3.01M
1,738.05%2.08M
759.33%2.58M
1,615.20%2.14M
72.28%174K
182.69%147K
413.64%113K
172.73%300K
267.65%125K
Non-operating interest income
1,966.67%3.6M
1,950.34%3.01M
1,738.05%2.08M
759.33%2.58M
1,615.20%2.14M
72.28%174K
182.69%147K
413.64%113K
172.73%300K
267.65%125K
Other net income (expense)
47.61%-877K
-424.68%-1.64M
-34.11%-401K
-490.30%-2.9M
-201.66%-611K
-1,187.69%-1.67M
49.19%-312K
-133.79%-299K
-40.11%742K
-82.67%601K
Gain on sale of security
----
----
----
-706.67%-182K
47,100.00%470K
-32,750.00%-653K
-50.00%1K
----
-94.09%30K
-100.72%-1K
Special income (charges)
14.10%-877K
-423.00%-1.64M
-34.11%-401K
-481.18%-2.71M
-279.57%-1.08M
-673.48%-1.02M
49.19%-313K
-134.85%-299K
-2.60%712K
-81.92%602K
-Less:Restructuring and merger&acquisition
-14.10%877K
423.00%1.64M
34.11%401K
481.18%2.71M
279.57%1.08M
673.48%1.02M
-49.19%313K
134.85%299K
2.60%-712K
81.92%-602K
Income before tax
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
Income tax
Net income
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
Net income continuous Operations
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
Minority interest income
Net income attributable to the parent company
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
Basic earnings per share
-92.63%-1.83
29.63%-0.57
32.95%-0.59
17.77%-2.36
38.52%-0.3566
-46.15%-0.95
-12.50%-0.81
17.76%-0.88
50.60%-2.87
-9.43%-0.58
Diluted earnings per share
-92.63%-1.83
29.63%-0.57
32.95%-0.59
17.77%-2.36
38.52%-0.3566
-46.15%-0.95
-12.50%-0.81
17.76%-0.88
50.60%-2.87
-9.43%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 747.51%79.34M179.55%23.23M182.42%23.07M54.01%38.67M106.52%12.83M53.38%9.36M34.84%8.31M23.21%8.17M-22.16%25.11M-1.86%6.21M
Selling and administrative expenses 1,382.73%49.2M243.61%10.89M196.85%8.47M36.95%13.48M72.36%4.14M42.28%3.32M28.46%3.17M7.98%2.85M-8.90%9.84M-7.47%2.4M
-General and administrative expense 1,382.73%49.2M243.61%10.89M196.85%8.47M36.95%13.48M72.36%4.14M42.28%3.32M28.46%3.17M7.98%2.85M-8.90%9.84M-7.47%2.4M
Research and development costs 398.73%30.14M140.07%12.34M174.68%14.6M65.01%25.19M128.06%8.69M60.25%6.04M39.10%5.14M33.30%5.32M-28.84%15.27M2.04%3.81M
Operating profit -747.51%-79.34M-179.55%-23.23M-182.42%-23.07M-54.01%-38.67M-106.52%-12.83M-53.38%-9.36M-34.84%-8.31M-23.21%-8.17M22.16%-25.11M1.86%-6.21M
Net non-operating interest income expense 1,966.67%3.6M1,950.34%3.01M1,738.05%2.08M759.33%2.58M1,615.20%2.14M72.28%174K182.69%147K413.64%113K172.73%300K267.65%125K
Non-operating interest income 1,966.67%3.6M1,950.34%3.01M1,738.05%2.08M759.33%2.58M1,615.20%2.14M72.28%174K182.69%147K413.64%113K172.73%300K267.65%125K
Other net income (expense) 47.61%-877K-424.68%-1.64M-34.11%-401K-490.30%-2.9M-201.66%-611K-1,187.69%-1.67M49.19%-312K-133.79%-299K-40.11%742K-82.67%601K
Gain on sale of security -------------706.67%-182K47,100.00%470K-32,750.00%-653K-50.00%1K-----94.09%30K-100.72%-1K
Special income (charges) 14.10%-877K-423.00%-1.64M-34.11%-401K-481.18%-2.71M-279.57%-1.08M-673.48%-1.02M49.19%-313K-134.85%-299K-2.60%712K-81.92%602K
-Less:Restructuring and merger&acquisition -14.10%877K423.00%1.64M34.11%401K481.18%2.71M279.57%1.08M673.48%1.02M-49.19%313K134.85%299K2.60%-712K81.92%-602K
Income before tax -605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M
Income tax
Net income -605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M
Net income continuous Operations -605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M
Minority interest income
Net income attributable to the parent company -605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M
Basic earnings per share -92.63%-1.8329.63%-0.5732.95%-0.5917.77%-2.3638.52%-0.3566-46.15%-0.95-12.50%-0.8117.76%-0.8850.60%-2.87-9.43%-0.58
Diluted earnings per share -92.63%-1.8329.63%-0.5732.95%-0.5917.77%-2.3638.52%-0.3566-46.15%-0.95-12.50%-0.8117.76%-0.8850.60%-2.87-9.43%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.